Are you Dr. Ahmann?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3838 N Campbell Ave
Tucson, AZ 85719Phone+1 520-694-2873
Summary
- Dr. Frederick Ahmann, MD is an oncologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona. He is affiliated with Banner - University Medical Center Tucson, Tucson VA Medical Center, and Banner - University Medical Center South.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1978 - 1980
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1974 - 1977
- University of Missouri-Columbia School of MedicineClass of 1974
Certifications & Licensure
- AZ State Medical License 1978 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:Arizona State Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Clinical Trials
- Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate Start of enrollment: 2007 Mar 01
- Selenium in Treating Patients With Prostate Cancer Start of enrollment: 2002 Aug 01
- Selenium in Preventing Prostate Cancer Start of enrollment: 2001 Aug 01
Publications & Presentations
PubMed
- 68 citationsComparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,63...William J Catalona, Jerome P Richie, Frederick R Ahmann, M'Liss A Hudson, Peter T Scardino
The Journal of Urology. 2017-02-01 - 132 citationsEffect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examinationJerome P. Richie, William J. Catalona, Frederick R. Ahmann, M'Liss A. Hudson, Peter T. Scardino
Urology. 1993-10-01 - 229 citationsDouble-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ...Tomasz M. Beer, Christopher W. Ryan, Peter Venner, Daniel P. Petrylak, Gurkamal Chatta
Journal of Clinical Oncology. 2007-02-09